Profitability Ratios
| Ratio |
Value |
| GP Margin |
15.1% |
| EBIT Margin |
-0.2% |
| EBITDA Margin |
5.9% |
| Operating Margin |
-0.2% |
| Pretax Margin |
-28.5% |
| Cont. Ops Margin |
-28.5% |
| Net Margin |
-28.5% |
| Bottom Line Margin |
-30.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.31 |
| Quick Ratio |
1.31 |
| Solvency Ratio |
-0.282 |
| Cash Ratio |
0.39 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.00 |
| Forward PEG |
-0.00 |
| Price/Book |
1.10 |
| Price/Sales |
0.24 |
| Price/FCF |
96.07 |
| Price/Op Cash Flow |
11.76 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5211 |
| Debt/Equity |
2.3837 |
| Debt/Capital |
0.7045 |
| Long-Term Debt/Capital |
0.7004 |
| Financial Leverage |
4.57 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
294.82 |
| Operating Cash Flow Ratio |
0.101 |
| Operating Cash Flow/Sales |
2.1% |
| Free Cash Flow/Operating Cash Flow |
12.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.53 |
| Interest Coverage |
-0.0772 |
| Short-Term Operating Cash Flow Coverage |
2.53 |
| Operating Cash Flow Coverage |
0.04 |
| Capital Expenditure Coverage |
1.14 |
| Dividend + Capital Expenditure Coverage |
0.86 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
-2.0817% |
| Dividend Yield |
2.4357% |
| Dividend Yield % |
2.4357% |
| Dividend Per Share |
0.0974 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
16.43 |
| EPS |
-4.680 |
| Debt/Share |
9.1690 |
| Cash/Share |
1.33 |
| Book Value/Share |
3.64 |
| Tangible BV/Share |
-7.57 |
| Equity/Share |
3.64 |
| Operating Cash Flow/Share |
0.340 |
| Capital Expenditure/Share |
0.298 |
| FCF/Share |
0.042 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
120.549 |
| Price/Fair Value |
1.10 |
| Debt/Market Cap |
2.1581 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
11.62 |
EVH - Evolent Health, Inc.